APA

Barker A. F., O'Donnell A. E., Flume P., Thompson P. J., Ruzi J. D., de Gracia J., Boersma W. G., De Soyza A., Shao L., Zhang J., Haas L., Lewis S. A., Leitzinger S., Montgomery A. B., McKevitt M. T., Gossage D., Quittner A. L. & O'Riordan T. G. (20151021). Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. : The Lancet. Respiratory medicine.

Chicago

Barker Alan F, O'Donnell Anne E, Flume Patrick, Thompson Philip J, Ruzi Jonathan D, de Gracia Javier, Boersma Wim G, De Soyza Anthony, Shao Lixin, Zhang Jenny, Haas Laura, Lewis Sandra A, Leitzinger Sheila, Montgomery A Bruce, McKevitt Matthew T, Gossage David, Quittner Alexandra L and O'Riordan Thomas G. 20151021. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. : The Lancet. Respiratory medicine.

Harvard

Barker A. F., O'Donnell A. E., Flume P., Thompson P. J., Ruzi J. D., de Gracia J., Boersma W. G., De Soyza A., Shao L., Zhang J., Haas L., Lewis S. A., Leitzinger S., Montgomery A. B., McKevitt M. T., Gossage D., Quittner A. L. and O'Riordan T. G. (20151021). Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. : The Lancet. Respiratory medicine.

MLA

Barker Alan F, O'Donnell Anne E, Flume Patrick, Thompson Philip J, Ruzi Jonathan D, de Gracia Javier, Boersma Wim G, De Soyza Anthony, Shao Lixin, Zhang Jenny, Haas Laura, Lewis Sandra A, Leitzinger Sheila, Montgomery A Bruce, McKevitt Matthew T, Gossage David, Quittner Alexandra L and O'Riordan Thomas G. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. : The Lancet. Respiratory medicine. 20151021.